
Sparsentan - Nephropathy
You are here : Home > Formulary Search > Sparsentan - Nephropathy
Status 1
- Tablets
This treatment is not provided by the Trusts in Surrey Heartlands but is on formulary at other local Trusts who provide renal services. Prescribing should remain with the specialist teams.
Locally, these specialist renal centres are at Brighton, Epsom and Frimley.
Documentation
- No records returned.
PAD Profile
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed implementation of sparsentan for treating primary IgA nephropathy in line with NICE TA 1074
Sparsentan for this indication will be considered as RED on the Joint Formulary with treatment initiation and continued prescribing by specialists in renal services
Primary care prescribers should be aware that their patient is receiving this medicine and ensure that this is recorded on the patient’s medication screen as a hospital-only drug in line with guidance on the PAD.
This will also alert the prescriber to potential side effects and interactions with other medicines prescribed in primary care. It will also ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.
Other Indications
Below are listed other indications that Sparsentan is used to treat.
- No records returned.